Different mutations in MAPT will contribute different morphological and biochemical characteristics to the tau filaments observed in the pathological inclusions of FTDP-17.[12] Clinical heterogeneity has also been demonstrated for several mutations, indicating the role of both environmental and other genetic risk factors. The gene discussed is MAPT; the disease is semantic dementia.